Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas Madrid Spain

Cochrane Response London UK

Departamento de Medicina Facultad de Medicina Universidad de Sevilla Seville Spain

Department of Clinical and Movement Neurosciences UCL Institute of Neurology Queen Square London UK

Department of Human Neurosciences Sapienza University of Rome Roma Italy

Department of Neurology and Center of Clinical Neuroscience 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Department of Neurology and Neurosurgery Institute of Clinical Medicine University of Tartu Tartu Estonia

Department of Neurology Centre d'Investigation Clinique Neurosciences Sorbonne Université Institut du Cerveau Paris Brain Institute ICM Assistance Publique Hôpitaux de Paris Inserm CNRS Pitié Salpêtrière Hospital Paris France

Department of Neurology Pirogov Russian National Research Medical University Moscow Russia

Department of Neurology UKSH Kiel Campus Christian Albrechts University Kiel Germany

Division of Neurology CHU of Grenoble Grenoble Institute of Neurosciences INSERM U1216 Grenoble Alpes University Grenoble France

Faculdade de Medicina da Universidade de Lisboa Lisbon Portugal

Faculdade de Medicina Universidade de Lisboa IMM Instituto de Medicina Molecular João Lobo Antunes Lisbon CNS Campus Neurológico Torres Vedras Portugal

IRCCS Neuromed Pozzilli Italy

Klinik f Neurologie Medizinische Universität Innsbruck Innsbruck Austria

Parkinson and Movement Disorders Unit Department of Neuroscience University of Padua Padova Italy

Tartu University Hospital Tartu Estonia

Unidad de Trastornos del Movimiento Servicio de Neurología y Neurofisiología Clínica Instituto de Biomedicina de Sevilla Hospital Universitario Virgen del Rocío CSIC Universidad de Sevilla Seville Spain

Eur J Neurol. 2023 Jun;30(6):1831-1833. doi: 10.1111/ene.15569. PubMed

Zobrazit více v PubMed

Hariz M, Bronstein JM, Cosgrove GR, et al. EAN/MDS-ES guidelines on pallidotomy for Parkinson's disease: Let's be accurate. Eur J Neurol. 2023;30(6):1831-1833.

Deuschl G, Antonini A, Costa J, et al. European academy of neurology/Movement Disorder Society - European section guideline on the treatment of Parkinson's disease: I. Invasive therapies. Eur J Neurol. 2022;29(9):2580-2595.

Deuschl G, Antonini A, Costa J, et al. European academy of neurology/Movement Disorder Society-European section guideline on the treatment of Parkinson's disease: I. Invasive therapies. Mov Disord. 2022;37(7):1360-1374.

Leone MA, Keindl M, Schapira AH, Deuschl G, Federico A. Practical recommendations for the process of proposing, planning and writing a neurological management guideline by EAN task forces. Eur J Neurol. 2015;22(12):1505-1510.

Rascol O, Goetz C, Koller W, Poewe W, Sampaio C. Treatment interventions for Parkinson's disease: an evidence based assessment. Lancet. 2002;359(9317):1589-1598.

Goetz CG, Poewe W, Rascol O, Sampaio C. Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Mov Disord. 2005;20(5):523-539.

Fox SH, Katzenschlager R, Lim SY, et al. The Movement Disorder Society evidence-based medicine review update: treatments for the motor symptoms of Parkinson's disease. Mov Disord. 2011;26(Suppl 3):S2-S41.

Fox SH, Katzenschlager R, Lim SY, et al. International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson's disease. Mov Disord. 2018;33(8):1248-1266.

Seppi K, Weintraub D, Coelho M, et al. The Movement Disorder Society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson's disease. Mov Disord. 2011;26(Suppl 3):S42-S80.

Kredo T, Bernhardsson S, Machingaidze S, et al. Guide to clinical practice guidelines: the current state of play. Int J Qual Health Care. 2016;28(1):122-128.

Guyatt GH, Oxman AD, Vist G, et al. GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). J Clin Epidemiol. 2011;64(4):407-415.

Zhang Y, Alonso-Coello P, Guyatt GH, et al. GRADE guidelines: 19. Assessing the certainty of evidence in the importance of outcomes or values and preferences-risk of bias and indirectness. J Clin Epidemiol. 2019;111:94-104.

Santesso N, Glenton C, Dahm P, et al. GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions. J Clin Epidemiol. 2020;119:126-135.

Merello M, Nouzeilles MI, Cammarota A, Betti O, Leiguarda R. Comparison of 1-year follow-up evaluations of patients with indication for pallidotomy who did not undergo surgery versus patients with Parkinson's disease who did undergo pallidotomy: a case control study. Neurosurgery. 1999;44(3):461-467.

Lozano AM, Lang AE, Galvez-Jimenez N, et al. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet. 1995;346(8987):1383-1387.

Ondo W, Jankovic J, Schwartz K, Almaguer M, Simpson RK. Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor. Neurology. 1998;51(4):1063-1069.

Merello M, Nouzeilles MI, Kuzis G, et al. Unilateral radiofrequency lesion versus electrostimulation of posteroventral pallidum: a prospective randomized comparison. Mov Disord. 1999;14(1):50-56.

Esselink RA, de Bie RM, de Haan RJ, et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology. 2004;62(2):201-207.

de Bie RM, de Haan RJ, Nijssen PC, et al. Unilateral pallidotomy in Parkinson's disease: a randomised, single-blind, multicentre trial. Lancet. 1999;354(9191):1665-1669.

Vitek JL, Bakay RA, Freeman A, et al. Randomized trial of pallidotomy versus medical therapy for Parkinson's disease. Ann Neurol. 2003;53(5):558-569.